GSK Current Ratio 2010-2022 | GSK

Current and historical current ratio for GSK (GSK) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. GSK current ratio for the three months ending June 30, 2022 was 1.43.
GSK Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $68.03B $47.50B 1.43
2022-03-31 $38.90B $32.58B 1.19
2021-12-31 $25.68B $32.55B 0.79
2021-09-30 $25.17B $30.91B 0.81
2021-06-30 $24.55B $29.90B 0.82
2021-03-31 $25.55B $27.96B 0.91
2020-12-31 $26.00B $28.44B 0.91
2020-09-30 $25.68B $28.65B 0.90
2020-06-30 $28.51B $29.69B 0.96
2020-03-31 $28.21B $32.45B 0.87
2019-12-31 $24.89B $30.71B 0.81
2019-09-30 $25.88B $31.46B 0.82
2019-06-30 $23.44B $33.14B 0.71
2019-03-31 $22.83B $31.86B 0.72
2018-12-31 $22.59B $30.02B 0.75
2018-09-30 $22.70B $23.97B 0.95
2018-06-30 $23.20B $24.77B 0.94
2018-03-31 $22.85B $37.47B 0.61
2017-12-31 $20.50B $34.24B 0.60
2017-09-30 $23.12B $35.92B 0.64
2017-06-30 $21.01B $36.81B 0.57
2017-03-31 $20.79B $23.23B 0.90
2016-12-31 $22.65B $25.75B 0.88
2016-09-30 $23.13B $23.82B 0.97
2016-06-30 $24.22B $25.98B 0.93
2016-03-31 $22.68B $19.94B 1.14
2015-12-31 $25.36B $20.52B 1.24
2015-09-30 $26.33B $19.77B 1.33
2015-06-30 $27.75B $21.13B 1.31
2015-03-31 $31.63B $23.93B 1.32
2014-12-31 $24.19B $21.91B 1.10
2014-09-30 $24.83B $25.52B 0.97
2014-06-30 $22.81B $20.62B 1.11
2014-03-31 $21.92B $19.31B 1.14
2013-12-31 $23.83B $21.40B 1.11
2013-09-30 $20.88B $19.89B 1.05
2013-06-30 $20.64B $19.17B 1.08
2013-03-31 $21.93B $18.66B 1.18
2012-12-31 $21.70B $21.90B 0.99
2012-09-30 $21.32B $22.06B 0.97
2012-06-30 $27.34B $24.39B 1.12
2012-03-31 $25.57B $22.83B 1.12
2011-12-31 $25.94B $24.08B 1.08
2011-09-30 $26.43B $21.13B 1.25
2011-06-30 $26.62B $22.23B 1.20
2011-03-31 $26.90B $20.99B 1.28
2010-12-31 $24.80B $19.51B 1.27
2010-09-30 $26.03B $17.42B 1.49
2010-06-30 $25.48B $17.91B 1.42
2010-03-31 $28.66B $18.98B 1.51
2009-12-31 $27.51B $18.98B 1.45
2009-09-30 $28.47B $18.26B 1.56
2009-06-30 $23.61B $13.99B 1.69
2009-03-31 $24.40B $14.02B 1.74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $73.273B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.361B 9.79
Bio-Rad Laboratories (BIO.B) United States $15.412B 34.05
QIAGEN (QGEN) Netherlands $11.336B 18.98
Biohaven Pharmaceutical Holding (BHVN) United States $10.564B 0.00
Ginkgo Bioworks Holdings (DNA) United States $6.449B 0.00
Arcus Biosciences (RCUS) United States $1.963B 38.31
Myovant Sciences (MYOV) United Kingdom $1.774B 0.00
Emergent Biosolutions (EBS) United States $1.521B 8.82
Zymeworks (ZYME) Canada $0.430B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Gelesis Holdings (GLS) United States $0.118B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
Ambrx Biopharma (AMAM) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00